Canada’s Regulators Hold J&J Vaccine for Safety Review

The New York Times | April 30, 2021, 9:55 p.m. | Original

The step was taken after Health Canada learned that an active ingredient was made in a Baltimore plant with contamination problems.

T.S.A. Extends Mask Mandate for Travel Into September Global Virus Cases Reach New Peak, Driven by India and South America